Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
PLSE

PLSE - Pulse Biosciences Inc Stock Price, Fair Value and News

$13.59-0.73 (-5.10%)
Market Closed

6/100

PLSE

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

6/100

PLSE

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$12.07

Target 3M

$13.58

Target 6M

$12.83

PLSE Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PLSE Price Action

Last 7 days

-5.4%

Last 30 days

-4.0%

Last 90 days

-19.6%

Trailing 12 Months

-29.7%

PLSE RSI Chart

PLSE Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

PLSE Valuation

Market Cap

921.0M

Price/Earnings (Trailing)

-12.32

Price/Sales (Trailing)

1.6K

EV/EBITDA

-12.7

Price/Free Cashflow

-18.88

PLSE Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$12.07

Target 3M

$13.58

Target 6M

$12.83

PLSE Fundamentals

PLSE Revenue

Revenue (TTM)

700.0K

Rev. Growth (Yr)

200%

Rev. Growth (Qtr)

20%

PLSE Earnings

Earnings (TTM)

-74.7M

Earnings Growth (Yr)

-52.88%

Earnings Growth (Qtr)

-1.13%

PLSE Profitability

Operating Margin

100.00%

EBT Margin

-9718.29%

Return on Equity

-80.62%

Return on Assets

-68.71%

Free Cashflow Yield

-5.3%

PLSE Investor Care

Shares Dilution (1Y)

10.16%

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20250000
20221.9M2.1M1.6M700.0K
202100682.0K1.4M
20200607.0K326.0K0
20190000
Get all data in R, Python etc through our Historical Stock Data APIs

About Pulse Biosciences Inc

PLSE
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.
 WEBSITEpulsebiosciences.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES61

Pulse Biosciences Inc Frequently Asked Questions

PLSE is the stock ticker symbol of Pulse Biosciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Pulse Biosciences Inc is 920.96 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check PLSE's fair value in chart for subscribers.

The fair value guage provides a quick view whether PLSE is over valued or under valued. Whether Pulse Biosciences Inc is cheap or expensive depends on the assumptions which impact Pulse Biosciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PLSE.

As of Wed Jan 28 2026, PLSE's PE ratio (Price to Earnings) is -12.32 and Price to Sales (PS) ratio is 1.58 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PLSE PE ratio will change depending on the future growth rate expectations of investors.